TRICARE Coverage for Macular Degeneration: 2026 Guide
## Quick answer TRICARE covers the diagnosis and treatment of Age-Related Macular Degeneration (AMD), including specialist visits with ophthalmologists, diagnostic imaging like OCT scans, and FDA-approved injectable medications like Lucentis or Avastin. Coverage is provided under your standard medical benefit, though costs vary depending on whether you are using a Prime or Select plan and whether the care is performed in an office or outpatient hospital setting.
*Note: TRICARE.Com is an independent reference site and is not the official TRICARE program. For official policy and the most current data, visit TRICARE.mil.*
In detail
Age-Related Macular Degeneration (AMD) is a leading cause of vision loss in older beneficiaries. TRICARE classifies most AMD treatments as "proven" and "medically necessary," meaning they are covered benefits rather than elective vision care.
### Covered Diagnostic Services Before treatment begins, TRICARE covers the following to confirm a diagnosis: * **Comprehensive Eye Exams:** Covered for all beneficiaries, though frequency depends on your plan (e.g., Prime vs. Select) and status (Active Duty vs. Retiree). * **Optical Coherence Tomography (OCT):** High-resolution imaging of the retina. * **Fluorescein Angiography:** A diagnostic procedure where dye is injected to highlight leaking blood vessels in the eye.
### Covered Treatments TRICARE covers treatments for both "Dry" and "Wet" AMD: * **Intravitreal Injections:** Coverage includes FDA-approved drugs such as aflibercept (Eylea), ranibizumab (Lucentis), and off-label but medically accepted bevacizumab (Avastin). These are typically administered in a specialist's office. * **Photodynamic Therapy (PDT):** Using a laser and light-sensitive medicine to treat leaking vessels. * **Laser Photocoagulation:** Thermal laser therapy for specific types of Wet AMD. * **Implantable Miniature Telescope (IMT):** Covered for certain patients with end-stage AMD, subject to specific clinical criteria.
### 2026 Cost Shares (Estimated) Costs depend on your beneficiary Group (Group A or B) and your specific plan. For **Retirees on TRICARE Select (Group A)** in 2026: * **Specialist Office Visit:** approximately $35–$40 per visit. * **Outpatient Hospital Setting:** A 20% cost-share of the TRICARE-allowed amount often applies if the injection is billed as an outpatient procedure. * **Prescription Drugs:** Injections administered by a doctor are usually billed as a medical claim (Part B-style) rather than through the Express Scripts pharmacy benefit.
### Contractor Responsibility * **East Region:** Managed by **Humana Military**. * **West Region:** Managed by **TriWest Healthcare Alliance** (as of Jan 1, 2025). * **Overseas:** Managed by **International SOS**.
## Who this applies to * **Retirees and Family Members:** This is the primary group affected by AMD. TRICARE Select and Prime both cover treatment, but Select users have more flexibility to choose a specialist without a referral. * **Active Duty Family Members (ADFMs):** Covered for all medically necessary eye treatments; Prime members typically have $0 out-of-pocket costs at network providers. * **TRICARE For Life (TFL) Beneficiaries:** Since AMD is an age-related condition, most TFL users (age 65+) use Medicare as primary and TRICARE as secondary. TRICARE will typically cover the remaining coinsurance not paid by Medicare for approved treatments.
Common scenarios
**Scenario 1: Retiree on TRICARE Select (West Region)** John, a 70-year-old retiree in California, is diagnosed with Wet AMD. He sees a network specialist under TriWest. Total bill for a Lucentis injection is $2,000. Under **2026 TRICARE Select rates**, John pays his $35–$50 specialist copay (if billed as an office visit) or a 20% cost-share if performed in a surgical center, until he hits his annual Catastrophic Cap.
**Scenario 2: Active Duty Spouse on TRICARE Prime (East Region)** Sarah is diagnosed with early-onset macular issues. She gets a referral from her Primary Care Manager (PCM) to an ophthalmologist in the Humana Military network. Because she is Prime and used a referral, her diagnostic OCT scans and subsequent treatments are **$0 out-of-pocket**.
**Scenario 3: TRICARE For Life (TFL) Beneficiary** Robert, age 74, receives monthly Eylea injections. Medicare pays 80% of the cost. TRICARE For Life, acting as the secondary payer, covers the remaining 20%. Robert's out-of-pocket cost is **$0**, provided the provider accepts Medicare and TRICARE.
## Related terms * **Ophthalmologist:** A medical doctor specializing in eye and vision care, who performs AMD surgery and injections. * **Optometrist:** Provides primary vision care; can diagnose AMD but often refers to an ophthalmologist for injections. * **Intravitreal Injection:** A shot of medicine into the eye's vitreous (the fluid in the back of the eye). * **Catastrophic Cap:** The maximum amount you pay out-of-pocket each year for covered TRICARE services. * **Medical Necessity:** The standard used by TRICARE to determine if a treatment (like a specific AMD drug) is eligible for coverage.
## Sources * **TRICARE.mil Covered Services (Vision):** https://www.tricare.mil/CoveredServices/IsItCovered/EyeExams * **Defense Health Agency (DHA) Medical Policy:** https://manuals.health.mil/ * **TriWest Healthcare Alliance (West Region):** https://www.triwest.com/ * **Humana Military (East Region):** https://www.humanamilitary.com/